The Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) is a flagship initiative under the Strengthening of Pharmaceuticals Industry (SPI) program, launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. This scheme aims to support MSME pharmaceutical manufacturers in upgrading their production facilities to meet national and international quality standards, ensuring global competitiveness in drug exports and compliance with import-related regulatory requirements.
For India’s pharmaceutical exporters and importers, RPTUAS provides critical financial assistance in modernizing infrastructure, enabling compliance with WHO-GMP, Schedule M, and global regulatory certifications.
Pharmaceutical manufacturing units can apply for the scheme if they meet the following conditions:
Step 1: Online application submission with detailed gap analysis.
Step 2: Evaluation by Project Management Consultant (PMC).
Step 3: Shortlisted applicant submits Revised Schedule M certificate and CA-certified expenditure proof.
Step 4: 1st Instalment (50% of subsidy, max ₹1 crore) released after SSC approval.
Step 5: Applicant submits WHO-GMP certificate and updated CA-certified expenditure.
Step 6: 2nd Instalment (remaining 50%, up to ₹1 crore) released.
The entire process is monitored by the Scheme Steering Committee (SSC) and the PMC.
Navigating the RPTUAS application and compliance process requires expert knowledge of DGFT, customs, and pharma regulations. Many MSMEs face challenges in documentation, certification, and subsidy claim verification.
At STAR GROUP, we specialize in assisting pharmaceutical importers and exporters with:
With STAR GROUP’s expertise, pharma businesses can seamlessly access RPTUAS benefits, enhance export readiness, and achieve global competitiveness.
It is a government scheme under the Department of Pharmaceuticals to provide capital subsidies to MSME pharma units for technology upgradation.
Any existing MSME pharmaceutical manufacturing unit with at least three years of operations.
Only investments made after 01 January 2024 are eligible.
maximum ₹2 crore per company, released in two equal installments.
Yes. The cost including customs duty, GST, and related charges is considered eligible.
Revised Schedule M certificate and WHO-GMP certificate.
The Project Management Consultant (PMC) and the Scheme Steering Committee (SSC).
In two installments: 50% after Revised Schedule M, and 50% after WHO-GMP certification.
No. Assets cannot be disposed of or diverted for at least five years.
Yes. All applications must be submitted online in the prescribed form.
